Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ultrasensitive Reagent for Ratiometric Detection and Detoxification of iAsIII in Water and Mitochondria.

Pasha SS. et al, (2022), Inorg Chem

9th International Symposium on Physical, Molecular, Cellular, and Medical Aspects of Auger Processes: Preface.

Vallis KA. et al, (2022), Int J Radiat Biol, 1 - 2

Impact of Cyclic Changes in Pharmacokinetics and Absorbed Dose in Pediatric Neuroblastoma Patients Receiving [177Lu]Lu-DOTATATE

VALLIS K. et al, (2022), EJNMMI Physics

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells

VALLIS K., (2022), Nature Chemistry

Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.

Brown T. et al, (2021), Angew Chem Int Ed Engl

3-Bromopyruvate-Mediated MCT1-Dependent Metabolic Perturbation Sensitizes Triple Negative Breast Cancer Cells to Ionizing Radiation

VALLIS K. et al, (2021), Cancer and Metabolism

Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks.

Abbott EM. et al, (2021), Clin Oncol (R Coll Radiol)

Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization and Delivery of Theranostic Radionuclides

VALLIS K., (2021), Molecular Pharmaceutics

Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer

Browning R. et al, (2021), Journal of Controlled Release

Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy

Owen J. et al, (2021), Nano Select

Interactive Contouring Through Contextual Deep Learning

Trimpl M. et al, (2021), Medical Physics

Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer

Abbott E. et al, (2021), Advances in Radiation Oncology, 6

Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy

Tiwari R. et al, (2021), Chemical Science, 12, 2667 - 2673

Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice.

Corroyer-Dulmont A. et al, (2021), Front Oncol, 11

Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.

Teoh S. et al, (2020), Radiother Oncol, 152, 151 - 162

The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients.

Abbott EM. et al, (2020), J Nucl Med, 61, 1658 - 1664

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: Mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Gill MR. et al, (2020), Chemical Science, 11, 8936 - 8944

An 111In-labelled bis-ruthenium(II) dipyridophenazine theranostic complex: Mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

VALLIS K., (2020), Chemical Science

Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?

Teoh S. et al, (2020), Br J Radiol, 93

Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.

Teoh S. et al, (2020), Br J Radiol

Load More

1
2
3
4
5
6
7
...
»